FDA approves preventive migraine treatment

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducin...

Posted: May 19, 2018 5:52 AM
Updated: May 19, 2018 5:52 AM

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

On Thursday, the US Food and Drug Administration approved Aimovig for the preventive treatment of migraines in adults with episodic or chronic migraines. Episodic migraine is when symptoms occur zero to 14 days each month; symptoms of chronic migraine occur 15 days or more a month.

The FDA has approved a preventive treatment option for migraine patients

It should be available within a week and is expected to cost $575 monthly or $6,900 annually

Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, or CGRP, a molecule that is involved in migraine attacks. Aimovig targets that molecule's receptor in your body.

The treatment, administered through monthly self-injections, requires a prescription and could be available to patients within a week. Aimovig is expected to cost $575 monthly or $6,900 annually in the United States.

There are three other migraine treatments in this newly emerging class of drugs.

Those drugs target the CGRP molecule itself, instead of its receptor. They are experimental but, if approved, might be made available to patients as early as this fall for one and next year for the others, said Dr. Stewart Tepper, director of the Dartmouth Headache Center at Dartmouth-Hitchcock Medical Center in New Hampshire, who was a clinical investigator in the Aimovig trials.

"When CGRP is released, outside of the brain, it causes inflammation and blood vessel dilation -- the blood vessels get big -- and that combination of inflammation and blood vessels getting big is the pain of migraine," said Tepper, who is also a professor of neurology at the Geisel School of Medicine at Dartmouth College.

Migraine is three times more common in women than in men and affects more than 10% of people worldwide, the FDA noted. In the US, about 12% of the population gets migraine headaches.

What was found in clinical trials

The effectiveness of Aimovig was evaluated in three key clinical trials.

The first included 955 people with a history of episodic migraine. Over the course of six months, those who received the treatment experienced one or two fewer monthly migraine days, on average, compared with a placebo.

The second study included 577 patients with a history of episodic migraine. Over the course of three months, those who received Aimovig treatment experienced one fewer migraine day per month.

The third study evaluated 667 patients with a history of chronic migraine. Over the course of three months, patients treated with Aimovig experienced, on average, 2- fewer monthly migraine days than those receiving a placebo.

"It may not get rid of all of them, but it really dramatically improves the frequency, severity and duration of the migraine attacks," Tepper said of the new treatment.

Patients "still will need to take something when they get a migraine attack, but this is the first designer medication to prevent migraine rather than treat as needed," he said.

In the clinical studies, the most common adverse side effects were pain at the injection site and constipation. The drug can be injected in the thigh, the abdomen or the outer area of the upper arm.

"The field is excited about a new drug that is specifically targeted for migraine mechanisms," said Dr. Teshamae Monteith, assistant professor of clinical neurology at the University of Miami and a member of the American Academy of Neurology, who was not involved in the development of the drug.

"Not only does the data show that it's effective for people who have what we call episodic migraine, but it's also effective for people who have chronic migraine," Monteith said.

"If you can imagine, a patient with chronic migraine has at least 15 days -- half the month -- with some type of headache, and eight days out of that month, it's what you would call a moderate to severe headache with associated symptoms, such as light sensitivity, sound sensitivity, some cognitive dysfunction, [gastrointestinal] symptoms and sometimes visual and motor symptoms," she said. "Patients can have fatigue, concentration impairment, neck stiffness and sometimes mood changes as well."

By Friday, Monteith was already receiving requests for prescriptions and questions about Aimovig from her patients, including Helene Good, who uses injections of Botox to treat her migraines.

'It's really exciting'

"I first heard about it when it showed up on my phone this morning as an article in my news, and I just happened to be on my way to see Dr. Monteith for my treatment today," Good said Friday.

"I read it to my spouse on the way over, and it's really exciting," said Good, a 63-year-old Miami resident who has had migraines since she was in her late teens.

"It's not like just having a bad headache. For me, it manifests in other ways," she said. "One side of my face droops, which sort of looks like I've had a mini stroke. I'm a pretty fast speaker, but my speech gets very slow."

When it comes to migraine treatment options, "you're always hoping and looking for hope," she said.

Treatment options for migraine sufferers typically depend on the frequency and severity of the migraine attacks. Patients who have episodic migraine usually rely on pain medications to treat the migraine pain. To avoid episodes, some patients may stay away from triggers, such as certain foods, lack of sleep or stress.

Before Aimovig, "the FDA-approved preventive medications for episodic migraine were only four. Two of them are beta blockers, anti-blood pressure medicines, and two of them are anti-epilepsy drugs," Tepper said.

"There was one FDA-approved treatment for chronic migraine, which was Botox," he said. For patients, "with our current preventive medicines, they have to take oral medicine every day, with the exception of Botox, which is given in 31 injections every 12 weeks."

Yet a problem with many of those other treatment options is that some are traditionally used for other disorders and have side effects, Monteith said.

"Not only are some of the drugs not effective for every patient, but then there's this issue with tolerability," she said. "Some of these drugs are not well-tolerated. In the right person, it's great, but certainly we need some other option."

Additionally, there are medical devices such as a FDA-approved nerve-stimulating "tiara" called Cefaly, another nerve-stimulating device called gammaCore and even an approach called transcranial magnetic stimulation. Some patients have turned to acupuncture for migraine therapy.

"As a headache specialist, there are a number of treatments that are available for our patients preventively for migraine, but many of them are associated with a lot of different side effects, and we've been waiting for the day when we can have a medication that specifically targets migraine and prevents it in this unique modality and is associated with few side effects," said Dr. Thomas Berk, headache neurologist at NYU Langone Health, who was not involved in the development of the new treatment.

"I've had a number of requests already from patients asking, is it possible to get it to them quickly? What are the ways of getting it, and the big question being, is my insurance going to cover it, which is a question that we don't really know particularly yet," he said. "Everyone's excited about it."

Minnesota Coronavirus Cases

Data is updated nightly.

Cases: 490011

Reported Deaths: 6618
CountyCasesDeaths
Hennepin1016821593
Ramsey43388811
Dakota36714394
Anoka33545392
Washington22247262
Stearns18847202
St. Louis14915265
Scott13445107
Wright12635116
Olmsted1187890
Sherburne879474
Carver790941
Clay696288
Rice678691
Blue Earth604435
Kandiyohi582274
Crow Wing523682
Chisago502945
Otter Tail487171
Benton451890
Winona419749
Mower411931
Douglas395068
Goodhue390169
Nobles387347
Polk345363
McLeod341950
Beltrami339151
Morrison328147
Itasca315346
Becker315143
Lyon314045
Isanti310056
Steele304311
Carlton300649
Freeborn287124
Pine283616
Nicollet263341
Todd250330
Brown249137
Le Sueur238620
Mille Lacs230047
Cass221424
Waseca211217
Meeker208534
Martin190829
Wabasha18733
Roseau181017
Hubbard161041
Houston158214
Dodge15464
Renville152940
Redwood147127
Fillmore14029
Pennington139816
Chippewa137035
Cottonwood136120
Wadena131520
Faribault125017
Aitkin119233
Sibley118310
Watonwan11838
Rock116314
Kanabec109120
Pipestone101924
Yellow Medicine97817
Murray9548
Jackson94710
Swift87818
Pope8185
Marshall78715
Stevens7478
Lake74318
Clearwater72014
Lac qui Parle68816
Wilkin67711
Koochiching62111
Big Stone5173
Lincoln5122
Grant4928
Norman4808
Unassigned45368
Mahnomen4437
Kittson41121
Red Lake3615
Traverse3115
Lake of the Woods2231
Cook1190

Iowa Coronavirus Cases

Data is updated nightly.

Cases: 337836

Reported Deaths: 5500
CountyCasesDeaths
Polk52116562
Linn19519317
Scott17180213
Black Hawk14973294
Woodbury13858214
Johnson1317875
Dubuque12452196
Dallas1023593
Pottawattamie9899146
Story965445
Warren515176
Clinton502884
Cerro Gordo501483
Webster495888
Sioux480469
Marshall465473
Des Moines428661
Muscatine426493
Buena Vista413337
Wapello4059110
Jasper388167
Plymouth369178
Lee354653
Marion341772
Jones285355
Henry279837
Bremer270655
Carroll266848
Crawford253435
Boone244830
Benton241554
Washington239247
Mahaska215846
Jackson210339
Dickinson204340
Tama203165
Kossuth198655
Delaware186340
Clay184525
Winneshiek183729
Fayette179535
Page178119
Buchanan178029
Wright174531
Hamilton173942
Cedar172923
Hardin170339
Harrison167870
Clayton160154
Butler159331
Mills148520
Floyd148141
Poweshiek148030
Cherokee146336
Lyon145741
Allamakee144948
Madison143318
Iowa140723
Hancock138030
Grundy132530
Winnebago130531
Calhoun129711
Cass129751
Jefferson128534
Appanoose123447
Louisa122644
Mitchell120740
Chickasaw119915
Union119331
Sac118818
Shelby117634
Emmet115440
Humboldt113925
Franklin109719
Guthrie109728
Palo Alto101721
Howard99722
Unassigned9790
Montgomery97036
Clarke95220
Keokuk92429
Monroe90028
Ida82132
Adair81630
Pocahontas80919
Davis76623
Monona76527
Greene73110
Lucas72321
Osceola68315
Worth6678
Taylor64112
Decatur5719
Fremont5619
Van Buren53818
Ringgold50720
Audubon4769
Wayne47521
Adams3194
Rochester/St. Mary'S
Clear
56° wxIcon
Hi: 57° Lo: 33°
Feels Like: 56°
Mason City
Clear
59° wxIcon
Hi: 61° Lo: 34°
Feels Like: 59°
Albert Lea
Partly Cloudy
54° wxIcon
Hi: 59° Lo: 36°
Feels Like: 54°
Austin
Partly Cloudy
55° wxIcon
Hi: 58° Lo: 32°
Feels Like: 55°
Charles City
Partly Cloudy
57° wxIcon
Hi: 61° Lo: 34°
Feels Like: 57°
Kicking off the workweek with warmer temperatures
KIMT Radar
KIMT Eye in the sky

Latest Video

Image

Sean's Weather 3/8

Image

Rochester NAACP President calls for accountability

Image

Rochester's Diversity Council talks racial inequality

Image

Mary Kristin Scott PKG

Image

Tailgate service

Image

Fewer babies being born

Image

Sara's Sunday Night Forecast

Image

Blooming Prairie GBB PKG

Image

Sara's Saturday Night Forecast

Image

Olmsted County Fair asks for help from lawmakers

Community Events